Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth O Hexner

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Genes & Development|June 15, 2017
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignanciesKaosheng Lv, Jing Jiang, Ryan Donaghy, et al.
The New England Journal of Medicine|July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host diseaseRan Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Blood|October 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsAlex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.
Leukemia|July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasmsTristan L Lim, David B Lieberman, Adam R Davis, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplantRachel V Hatch, Craig W Freyer, Alison Carulli, et al.
NPJ Breast Cancer|November 12, 2022
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancerIgor Makhlin, Nicholas P McAndrew, E Paul Wileyto, et al.
Leukemia & Lymphoma|June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma|March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemiaMolly E Graveno, Alison Carulli, Craig W Freyer, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|May 26, 2018
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, Noelle V Frey, Elizabeth O Hexner, et al.
Genes & Development|June 15, 2017
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignanciesKaosheng Lv, Jing Jiang, Ryan Donaghy, et al.
The New England Journal of Medicine|July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host diseaseRan Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Blood|October 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHDYing Wang, Shan He, Gennaro Calendo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsAlex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.
Leukemia|July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasmsTristan L Lim, David B Lieberman, Adam R Davis, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplantRachel V Hatch, Craig W Freyer, Alison Carulli, et al.
NPJ Breast Cancer|November 12, 2022
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancerIgor Makhlin, Nicholas P McAndrew, E Paul Wileyto, et al.
Leukemia & Lymphoma|June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma|March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemiaMolly E Graveno, Alison Carulli, Craig W Freyer, et al.
Pageof 11